Fine needle aspiration of renal cortical lesions in adults

Diagnostic Cytopathology

Volumn 38, Issue 10, 2010, Pages 710-715

  Adeniran, Adebowale J ^a,c   Al Ahmadie, Hikmat ^a   Iyengar, Pratibha ^b   Reuter, Victor E ^a   Lin, Oscar ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CREDIT VALLEY HOSPITAL   (Canada)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aspiration; Carcinoma; Fine; Kidney; Needle

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADULT; ANGIOMYOLIPOMA; ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; COLON CARCINOMA; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; KIDNEY CORTEX; MAJOR CLINICAL STUDY; METASTASIS; ONCOCYTOMA; PAPANICOLAOU TEST; PAPILLARY CARCINOMA; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; SMALL CELL SARCOMA; UROGENITAL TRACT TUMOR;

BIOPSY, FINE-NEEDLE; CARCINOMA, RENAL CELL; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; KIDNEY NEOPLASMS;

EID: 77957696540     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21274     Document Type: Article

References (37)

1. Renshaw AA, Granter SR, Cibas ES. Fine-needle aspiration of the adult kidney. Cancer 1997;81:71-88.
2. Campbell SC, Novick AC, Herts B, et al. Prospective evaluation of fine needle aspiration of small, solid renal masses: Accuracy and morbidity. Urology 1997;50:25-29. (Pubitemid 27300360)
3. Berg WJ, McCaffrey J, Schwartz LH, Mariani T, Mazumdar M, Motzer RJ. A phase II study of pyrazoloacridine in patients with advanced renal cell carcinoma. Invest New Drugs 1998;16:337-340.
4. Berg WJ, Schwartz L, Yu R, Mazumdar M, Motzer RJ. Phase II trial of irofulven (6-hydroxymethylacylfulvene) for patients with advanced renal cell carcinoma. Invest New Drugs 2001;19:317-320. (Pubitemid 32782972)
5. McKiernan J, Yossepowitch O, Kattan MW, et al. Partial nephrectomy for renal cortical tumors: Pathologic findings and impact on outcome. Urology 2002;60:1003-1009. (Pubitemid 35447555)
6. Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 2002;20:289-296. (Pubitemid 34032623)
7. Motzer RJ, Bacik J, Schwartz LH, et al. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 2004;22:454-463. (Pubitemid 41079774)
8. Motzer RJ, Berg W, Ginsberg M, et al. Phase II trial of thalidomide for patients with advanced renal cell carcinoma. J Clin Oncol 2002;20:302-306.
9. Motzer RJ, Rakhit A, Thompson J, et al. Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma. Ann Oncol 2002;13:1799-1805.
10. Vuky J, Yu R, Schwartz L, Motzer RJ. Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma. Invest New Drugs 2002;20:327-330. (Pubitemid 34823761)
11. Granter SR, Renshaw AA. Fine-needle aspiration of chromophobe renal cell carcinoma. Analysis of six cases. Cancer 1997;81:122-128.
12. Hidvegi D, DeMay RM, Nunez-Alonso C, Nieman HL. Percutaneous transperitoneal aspiration of renal adenocarcinoma guided by ultrasound. Morphologic appearance of normal and malignant cells. Acta Cytol 1979;23:467-470.
13. Liu J, Fanning CV. Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies. Cancer 2001;93:390-397.
14. Murphy WM, Zambroni BR, Emerson LD, Moinuddin S, Lee LH. Aspiration biopsy of the kidney. Simultaneous collection of cytologic and histologic specimens. Cancer 1985;56:200-205.
15. Renshaw AA, Lee KR, Madge R, Granter SR. Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma. Acta Cytol 1997;41:987-994. (Pubitemid 27329670)
16. Salamanca J, Alberti N, Lopez-Rios F, Perez-Barrios A, Martinez-Gonzalez MA, de Agustin P. Fine needle aspiration of chromophobe renal cell carcinoma. Acta Cytol 2007;51:9-15.
17. Truong LD, Todd TD, Dhurandhar B, Ramzy I. Fine-needle aspiration of renal masses in adults: Analysis of results and diagnostic problems in 108 cases. Diagn Cytopathol 1999;20:339-349. (Pubitemid 29239365)
18. Zardawi IM. Renal fine needle aspiration cytology. Acta Cytol 1999;43:184-190. (Pubitemid 29144712)
19. Renshaw AA, Corless CL. Papillary renal cell carcinoma. Histology and immunohistochemistry. Am J Surg Pathol 1995;19:842-849.
20. Dekmezian R, Sneige N, Shabb N. Papillary renal-cell carcinoma: Fine-needle aspiration of 15 cases. Diagn Cytopathol 1991;7:198-203.
21. Flint A, Cookingham C. Cytologic diagnosis of the papillary variant of renal-cell carcinoma. Acta Cytol 1987;31:325-329.
22. Lewi HJ, Alexander CA, Fleming S. Renal oncocytoma. Br J Urol 1986;58:12-15.
23. Nguyen GK, Amy RW, Tsang S. Fine needle aspiration biopsy cytology of renal oncocytoma. Acta Cytol 1985;29:33-36. (Pubitemid 15174454)
24. Renshaw AA, Granter SR. Fine needle aspiration of chromophobe renal cell carcinoma. Acta Cytol 1996;40:867-872.
25. Pancholi V, Munjal K, Jain M, Munjal S, Agrawal R, Nandedkar S. Preoperative diagnosis of renal angiomyolipoma with fine needle aspiration cytology: A report of 3 cases. Acta Cytol 2006;50:466-468. (Pubitemid 44141211)
26. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumours. J Pathol 1997;183:131-133.
27. Eble JNSG, Epstein JI, Sesterhenn IA. Pathology and genetics. Tumors of the urinary system and male genital organs. Lyon: IARC Press; 2004.
28. Motzer RJ, Schwartz L, Law TM, et al. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: Antitumor activity in a phase II trial and interactions in vitro. J Clin Oncol 1995;13:1950-1957.
29. Berg WJ, Schwartz LH, Amsterdam A, et al. A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma. Invest New Drugs 1997;15:353-355.
30. Eisen T, Boshoff C, Mak I, et al. Continuous low dose Thalidomide: A phase II study in advanced melanoma, renal cell, ovarian and breast cancer. Br J Cancer 2000;82:812-817. (Pubitemid 30085231)
31. Chowdhury S, Choueiri TK. Recent advances in the systemic treatment of metastatic papillary renal cancer. Expert Rev Anticancer Ther 2009;9:373-379.
32. Kelley CM, Cohen MB, Raab SS. Utility of fine-needle aspiration biopsy in solid renal masses. Diagn Cytopathol 1996;14:14-19.
33. Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 2000;75:1236-1242.
34. Leiman G. Audit of fine needle aspiration cytology of 120 renal lesions. Cytopathology 1990;1:65-72.
35. Lerner SE, Hawkins CA, Blute ML, et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 1996;155:1868-1873.
36. Mancilla-Jimenez R, Stanley RJ, Blath RA. Papillary renal cell carcinoma: A clinical, radiologic, and pathologic study of 34 cases. Cancer 1976;38:2469-2480.
37. Al-Ahmadie HAAD, Olgac S, Fine SW, Gopalan A, Tickoo SK, Reuter VE. The role of immunohistochemical evaluation of adult renal cortical tumors on core biopsy: An ex-vivo study. Mod Pathol 2007;20:134A.